Company news
Rani Therapeutics Holdings, Inc. news in 2022
Rani Therapeutics Holdings, Inc.'s news releases, calls and decks from 2022, newest first.
Rani Therapeutics Announces Repeat-Dose Topline Results from RT-102 Phase 1 Study
December 5, 2022
Rani Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 9, 2022
Rani Therapeutics Announces New RT-111 Development Program and Provides Corporate Update
October 23, 2022
Rani Therapeutics Announces Termination of Public Offering of Class A Common Stock
August 10, 2022
Rani Therapeutics Announces Proposed Public Offering of Class A Common Stock
August 9, 2022
Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of RT-102 in Osteoporosis
August 9, 2022
Rani Therapeutics Enters into $45 Million Loan Agreement to Support Ongoing RaniPill® Platform Advancement and Clinical Pipeline Development
August 7, 2022
Rani Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results; Provides Corporate Update
March 28, 2022
Rani Therapeutics Announces Initiation of Phase 1 Study of RT-102 Oral PTH for Osteoporosis
March 22, 2022
Rani Therapeutics Unveils High-Capacity RaniPill™ Device For Oral Delivery of Biologics; Reports Preliminary 2021 Consolidated Financial Results
February 22, 2022
Rani Therapeutics Appoints Lisa Rometty to Board of Directors
January 6, 2022
Decks in 2022
- Technical Presentation (December 2022)
Technical · 22 slides · Dec 6, 2022
- Technical Presentation (December 2022)
Technical · 30 slides · December 2022
- Investor Presentation (February 2022)
Investor deck · 25 slides · February 2022